Skip to content
healthcare.dev
Get a free key

Rivaroxaban

NDC 67877-882, Rivaroxaban, granule, for suspension, from Ascend Laboratories, LLC.

Product NDC
67877-882
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA218502
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-882 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RIVAROXABAN155 mg/1

Pharmacologic classes

Factor Xa Inhibitor [EPC]; Factor Xa Inhibitors [MoA]

Package NDCNDC-11Package
67877-882-71678770882711 BOTTLE in 1 CARTON (67877-882-71) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0efa9f9-ca7a-471a-8030-99056fa5da09

  • NADAC price for package 67877088271

    GET /v1/drugs/nadac/67877088271

Use it

Look up 67877-882 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-882 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-882. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.